Cargando…

Pemigatinib in previously treated Chinese patients with locally advanced or metastatic cholangiocarcinoma carrying FGFR2 fusions or rearrangements: A phase II study

OBJECTIVE: This study evaluated the antitumor activity and safety of pemigatinib in previously treated Chinese patients with advanced cholangiocarcinoma and fibroblast growth factor receptor 2 (FGFR2) fusions or rearrangements. BACKGROUND: Pemigatinib provided clinical benefits for previously treate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Guo‐Ming, Huang, Xiao‐Yong, Wen, Tian‐Fu, Song, Tian‐Qiang, Kuang, Ming, Mou, Hai‐Bo, Bao, Le‐Qun, Zhao, Hai‐Tao, Zhao, Hong, Feng, Xie‐Lin, Zhang, Bi‐Xiang, Peng, Tao, Zhang, Yu‐Bao, Li, Xiang‐Cheng, Yu, Hong‐Sheng, Cao, Yu, Liu, Lian‐Xin, Zhang, Ti, Wang, Wei‐Lin, Ran, Jiang‐Hua, Liu, Ying‐Bin, Gong, Wei, Chen, Ming‐Xia, Cao, Lian, Luo, Yang, Wang, Yan, Zhou, Hui, Yang, Guo‐Huan, Fan, Jia, Zhou, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972033/ https://www.ncbi.nlm.nih.gov/pubmed/36127767 http://dx.doi.org/10.1002/cam4.5273

Ejemplares similares

Characterization of the cholangiocarcinoma drug pemigatinib against FGFR gatekeeper mutants
por: Lin, Qianmeng, et al.
Publicado: (2022)

Pemigatinib for cholangiocarcinoma
Publicado: (2022)

Pemigatinib for adults with previously treated, locally advanced or metastatic cholangiocarcinoma with FGFR2 fusions/rearrangements
por: Walden, Daniel, et al.
Publicado: (2022)

Activity of Pemigatinib in Pilocytic Astrocytoma and FGFR1(N546K) Mutation
por: Capone, Stephen, et al.
Publicado: (2022)

Population Pharmacokinetics Analysis of Pemigatinib in Patients With Advanced Malignancies
por: Ji, Tao, et al.
Publicado: (2022)

FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with FGFR2 rearrangements
por: Bekaii-Saab, Tanios S, et al.
Publicado: (2020)

Pemigatinib treatment for intrahepatic cholangiocarcinoma with FGFR2 fusion detected by a liquid comprehensive genomic profiling test
por: Ishido, Shun, et al.
Publicado: (2023)

Population pharmacokinetic and exposure‐response analyses of pemigatinib in patients with advanced solid tumors including cholangiocarcinoma
por: Gong, Xiaohua, et al.
Publicado: (2023)

Pemigatinib in Intrahepatic Cholangiocarcinoma: A Work in Progress
por: Gadaleta-Caldarola, Gennaro, et al.
Publicado: (2022)

Hyperphosphatemic Tumoral Calcinosis With Pemigatinib Use
por: Puar, Akshan, et al.
Publicado: (2022)

Evaluation of the clinical cardiac safety of pemigatinib, a fibroblast growth factor receptor inhibitor, in participants with advanced malignancies
por: Gong, Xiaohua, et al.
Publicado: (2021)

FIGHT‐102: A phase 1 study of pemigatinib in Japanese patients with advanced malignancies
por: Fujiwara, Yutaka, et al.
Publicado: (2023)

Case Report: Persistent response to combination therapy of pemigatinib, chemotherapy, and immune checkpoint inhibitor in a patient with advanced intrahepatic cholangiocarcinoma
por: Zhang, Zhuochao, et al.
Publicado: (2023)

Evaluation of drug–drug interaction potential for pemigatinib using physiologically based pharmacokinetic modeling
por: Ji, Tao, et al.
Publicado: (2022)

Inhibition of MCF-7 breast cancer cell-induced platelet aggregation using a combination of antiplatelet drugs
por: LIAN, LIAN, et al.
Publicado: (2013)

X-linked Charcot-Marie-Tooth disease after SARS-CoV-2 vaccination mimicked stroke-like episodes: A case report
por: Zhang, Qiang, et al.
Publicado: (2023)

Clinical and epidemiological investigation of a child with asymptomatic COVID-19 infection following reoccurrence
por: Lin, Qiu‑Yu, et al.
Publicado: (2022)

Mechanistic target of rapamycin kinase (Mtor) is required for spermatogonial proliferation and differentiation in mice
por: Cao, Jun, et al.
Publicado: (2019)

Clinical experience with pemigatinib for previously treated metastatic cholangiocarcinoma: practical considerations from clinical cases
por: Wadsley, Jonathan, et al.
Publicado: (2023)

Multifocal serous retinopathy with pemigatinib therapy for metastatic colon adenocarcinoma
por: Alekseev, Oleg, et al.
Publicado: (2021)

Different processes shape the patterns of divergence in the nuclear and chloroplast genomes of a relict tree species in East Asia
por: Tian, Xiang‐Yu, et al.
Publicado: (2020)

FGFR2-ERC1: A Subtype of FGFR2 Oncogenic Fusion Variant in Lung Adenocarcinoma and the Response to Anlotinib
por: Hong, Chen, et al.
Publicado: (2022)

FGF2/FGFR1 regulates autophagy in FGFR1-amplified non-small cell lung cancer cells
por: Yuan, Hong, et al.
Publicado: (2017)

Suspending Effect on Low-Frequency Charge Noise in Graphene Quantum Dot
por: Song, Xiang-Xiang, et al.
Publicado: (2015)

Sprouty2 suppresses progression and correlates to favourable prognosis of intrahepatic cholangiocarcinoma via antagonizing FGFR2 signalling
por: Xu, Yun‐Fei, et al.
Publicado: (2018)

A phase II trial of the FGFR inhibitor pemigatinib in patients with metastatic esophageal–gastric junction/gastric cancer trastuzumab resistant: the FiGhTeR trial
por: Merz, Valeria, et al.
Publicado: (2020)

Effects of combined high pressure and enzymatic treatments on physicochemical and antioxidant properties of peanut proteins
por: Dong, Xin‐hong, et al.
Publicado: (2019)

Safety analysis of pemigatinib leveraging the US Food and Drug administration adverse event reporting system
por: Zhang, Ying, et al.
Publicado: (2023)

A new promising oncogenic target (p.C382R) for treatment with pemigatinib in patients with cholangiocarcinoma
por: Hempel, Louisa, et al.
Publicado: (2022)

Circ_0015756 Aggravates Hepatocellular Carcinoma Development by Regulating FGFR1 via Sponging miR-610
por: Guo, Weisheng, et al.
Publicado: (2020)

Noninvasive detection and interpretation of gastrointestinal diseases by collaborative serum metabolite and magnetically controlled capsule endoscopy
por: Yu, Xiang-Tian, et al.
Publicado: (2022)

Development of a predictive model for increasing sperm retrieval success by microdissection testicular sperm extraction in patients with nonobstructive azoospermia
por: Deng, Chen-Yao, et al.
Publicado: (2023)

Organocatalytic Asymmetric Aldol Reaction of Arylglyoxals and Hydroxyacetone: Enantioselective Synthesis of 2,3-Dihydroxy-1,4-diones
por: Zhou, Yu-Hao, et al.
Publicado: (2020)

Correction: ErbB4 deletion in noradrenergic neurons in the locus coeruleus induces mania-like behavior via elevated catecholamines
por: Cao, Shu-Xia, et al.
Publicado: (2019)

ErbB4 deletion in noradrenergic neurons in the locus coeruleus induces mania-like behavior via elevated catecholamines
por: Cao, Shu-Xia, et al.
Publicado: (2018)

Circ-ERC2 Is Involved in Melatonin Synthesis by Regulating the miR-125a-5p/MAT2A Axis
por: Guo, Hai-Xiang, et al.
Publicado: (2022)

Effect of autogenous osteochondral mosaicplasty on the balance control of patients with cartilage defects of the knee: a pilot study
por: Tao, Hai, et al.
Publicado: (2023)

High tibial osteotomy improves balance control in patients with knee osteoarthritis and a varus deformity
por: Zhang, Zheng, et al.
Publicado: (2023)

Psychological status of infertile men during the Coronavirus Disease 2019 Pandemic in China: a cross-sectional investigation
por: Zhang, Zhe, et al.
Publicado: (2023)

Characterization of short-chain fatty acids in patients with ulcerative colitis: a meta-analysis
por: Xu, Hao-Ming, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_652e6m45d835f21rba2ad4s9uq